As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Studies have long warned that blows to the head may raise the risk of neurodegenerative conditions. Now, scientists believe ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

Recent studies implicate the immune system and a herpes virus as potential contributors to development of the disease.

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step ... 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Dogs with a bacterial infection feel an increased need to urinate. Some dogs will have dark urine or other signs of illness and, when treated with antibiotics and other treatments, this can clear up ...

Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...